Abeona Therapeutics
ABEO
ABEO
55 hedge funds and large institutions have $182M invested in Abeona Therapeutics in 2024 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 18 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
7.21% less ownership
Funds ownership: 73.59% → 66.38% (-7.2%)
11% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 18
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
55
Holding in Top 10
2
Calls
$4.08M
Puts
$304K
Top Buyers
| 1 | +$1.27M | |
| 2 | +$798K | |
| 3 | +$702K | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$532K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$525K |
Top Sellers
| 1 | -$3.94M | |
| 2 | -$2.65M | |
| 3 | -$2.37M | |
| 4 |
Renaissance Technologies
New York
|
-$2.33M |
| 5 |
LCM
Laurion Capital Management
New York
|
-$1.27M |